What stocks have a 5 star Morningstar rating?
Morningstar assigns its coveted 5-star rating to equities that are trading at a substantial discount to the firm's internal estimate of intrinsic fair value, adjusted for uncertainty. Because stock prices and analyst valuations fluctuate constantly based on market volatility, the exact roster of 5-star undervalued stocks changes weekly. Companies entering this tier typically span temporarily depressed large-cap technology firms, healthcare leaders, or cyclical enterprises experiencing short-term market pessimism.
Related FAQs
Morningstar is frequently evaluated by quality-focused and long-term investors as an appealing purchase due to its dominant brand recognition, high customer retention rates, and reliable recurring revenue streams across global financial advisory mark...
Morningstar Inc. operates as a leading provider of independent investment research and financial data, exposing shareholders to specific financial services risks.
Morningstar stock is widely regarded by institutional analysts as a solid long-term investment, underpinned by its irreplaceable financial database, trusted research independence, and essential role in the global wealth management ecosystem.
Equity research analysts tracking Morningstar, Inc.
Executive compensation for the chief executive officer guiding The Mosaic Company (a leading global producer and marketer of concentrated phosphate and potash crop nutrients) reflects agricultural sector benchmarks.
Determining the trustworthiness and financial stability of Mutual of Omaha—a major mutual insurance and financial services corporation founded in the United States—involves examining its independent credit ratings and long-term solvency.
Zacks Number 1 rated stocks, officially known within the platform as Zacks Rank #1 (Strong Buy) equities, are companies that have demonstrated the most compelling upward revisions in their forward earnings estimates by professional brokerage analysts...
Consensus analyst price targets for Morningstar, Inc. (NASDAQ: MORN) average approximately $299.60, with high-end institutional estimates reaching up to $370.00.